At this meeting, leading experts from both academia and the pharmaceutical industry will describe new research that is beginning to shed light on a number of aspects that relate to both normal brain physiology and pathophysiology that will lay the foundations towards discovering and developing improved diagnostics, clinical biomarkers and therapies for a wide range of neurological disorders.